НовостиBenzingaHC Wainwright & Co. Maintains Buy on Actuate Therapeutics, Lowers Price Target to $10 HC Wainwright & Co. Maintains Buy on Actuate Therapeutics, Lowers Price Target to $10 Benzinga 2026.11.16 12:18 (GMT+0) Открыть на Benzinga Другие новости